MX2013010961A - Derivados novedosos de cefalosporinas y composiciones farmaceuticas de estos. - Google Patents
Derivados novedosos de cefalosporinas y composiciones farmaceuticas de estos.Info
- Publication number
- MX2013010961A MX2013010961A MX2013010961A MX2013010961A MX2013010961A MX 2013010961 A MX2013010961 A MX 2013010961A MX 2013010961 A MX2013010961 A MX 2013010961A MX 2013010961 A MX2013010961 A MX 2013010961A MX 2013010961 A MX2013010961 A MX 2013010961A
- Authority
- MX
- Mexico
- Prior art keywords
- cephalosporin derivative
- novel cephalosporin
- chemical formula
- composition containing
- medical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/60—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 3 and 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
La presente invención se refiere a derivados novedosos de cefalosporinas representados por la fórmula química 1. (Ver Formula) Donde X, Y, L, R1 y R2 son los mismos que se han definido en la descripción de la invención. La presente invención también se refiere a composiciones antibióticas farmacéuticas que comprenden un derivado novedoso de cefalosporinas representado por la fórmula química 1, un profármaco de este, un hidrato de este, un solvato de este, un isómero de este o una sal farmaceúticamente aceptable de este como principio eficaz. De acuerdo con la presente invención, los derivados novedosos de cefalosporinas, un profármaco de estos, un hidrato de estos, un solvato de estos, un isómero de estos o una sal farmacéuticamente aceptable de estos pueden ser útiles como antibióticos debido a su amplio espectro contra bacterias resistentes a antibióticos, su baja toxicidad y especialmente su potente efecto antibacteriano en bacterias gramnegativas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110028603A KR101719556B1 (ko) | 2011-03-30 | 2011-03-30 | 신규한 세파로스포린 유도체 및 이를 함유하는 의약 조성물 |
PCT/KR2012/002302 WO2012134184A2 (ko) | 2011-03-30 | 2012-03-29 | 신규한 세파로스포린 유도체 및 이를 함유하는 의약 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2013010961A true MX2013010961A (es) | 2014-03-27 |
MX359435B MX359435B (es) | 2018-09-28 |
Family
ID=46932135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013010961A MX359435B (es) | 2011-03-30 | 2012-03-29 | Derivados novedosos de cefalosporinas y composiciones farmaceuticas de estos. |
Country Status (27)
Country | Link |
---|---|
US (2) | US8329684B2 (es) |
EP (1) | EP2706062B1 (es) |
JP (1) | JP6144669B2 (es) |
KR (1) | KR101719556B1 (es) |
CN (1) | CN103547583B (es) |
AU (1) | AU2012237063B2 (es) |
BR (1) | BR112013025275A2 (es) |
CA (1) | CA2831421C (es) |
CL (1) | CL2013002820A1 (es) |
CO (1) | CO6821935A2 (es) |
CR (1) | CR20130501A (es) |
CU (1) | CU20130125A7 (es) |
DK (1) | DK2706062T3 (es) |
DO (1) | DOP2013000214A (es) |
EA (1) | EA024709B1 (es) |
ES (1) | ES2683351T3 (es) |
HR (1) | HRP20181170T1 (es) |
HU (1) | HUE039086T2 (es) |
IL (1) | IL228408A (es) |
LT (1) | LT2706062T (es) |
MX (1) | MX359435B (es) |
PL (1) | PL2706062T3 (es) |
PT (1) | PT2706062T (es) |
SG (1) | SG193998A1 (es) |
SI (1) | SI2706062T1 (es) |
WO (1) | WO2012134184A2 (es) |
ZA (1) | ZA201308078B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2702257C (en) | 2007-10-09 | 2016-07-12 | Sopharmia, Inc. | Broad spectrum beta-lactamase inhibitors |
JP2017527604A (ja) | 2014-09-17 | 2017-09-21 | アイアンウッド ファーマシューティカルズ インコーポレイテッド | sGC刺激剤 |
US10059680B2 (en) * | 2014-12-18 | 2018-08-28 | Merck Sharp & Dohme Corp. | Thiadiazolyl-oximinoacetic acid derivative compounds |
US20160176897A1 (en) | 2014-12-23 | 2016-06-23 | Merck Sharp & Dohme Corp. | 7-aminocephem derivative compounds |
AU2016367284C1 (en) | 2015-12-10 | 2018-09-20 | Naeja-Rgm Pharmaceuticals Ulc | Cephem compounds, their production and use |
EP3526225A1 (en) * | 2016-10-14 | 2019-08-21 | Universidade do Porto | Hydroxycinnamic derivatives, methods and uses thereof |
KR20180093307A (ko) * | 2017-02-13 | 2018-08-22 | 주식회사 레고켐 바이오사이언스 | 4, 5-디아미노 치환 피리미딘 유도체의 제조방법 및 이를 제조하기 위한 신규한 화합물 |
WO2019145784A2 (en) * | 2018-01-26 | 2019-08-01 | Legochem Biosciences, Inc. | Combination therapies for multi-drug resistant pathogens |
CN109762791B (zh) * | 2018-11-19 | 2021-02-09 | 厦门联合安金生物工程有限公司 | 包含BPI-Fc嵌合基因的重组腺病毒及其用途 |
CN111471058A (zh) * | 2019-01-23 | 2020-07-31 | 中国医学科学院药物研究所 | 用于制备头孢吡普类似物的方法 |
US20220332728A1 (en) | 2019-09-06 | 2022-10-20 | Nabriva Therapeutics GmbH | Siderophore cephalosporin conjugates and uses thereof |
CN111635377A (zh) * | 2020-06-30 | 2020-09-08 | 南京红杉生物科技有限公司 | 噻二唑类化合物及其合成方法 |
KR20220152157A (ko) * | 2021-05-07 | 2022-11-15 | 한국생명공학연구원 | 신규 사이드로포어 화합물 및 이를 이용한 금속 나노입자 복합체 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3006888A1 (de) * | 1980-02-23 | 1981-09-10 | Hoechst Ag, 6000 Frankfurt | Cephalosporinderivate und verfahren zu ihrer herstellung |
EP0303172A3 (de) * | 1987-08-14 | 1991-05-15 | F. Hoffmann-La Roche Ag | Oxyimino-Cephalosporine |
GB8817653D0 (en) * | 1988-07-25 | 1988-09-01 | Fujisawa Pharmaceutical Co | New cephem compounds & processes for preparation thereof |
GB9111406D0 (en) * | 1991-05-28 | 1991-07-17 | Fujisawa Pharmaceutical Co | New cephem compounds and processes for preparation thereof |
US5498777A (en) * | 1994-07-20 | 1996-03-12 | Merck & Co., Inc. | 3-thioheteroaryl cephalosporin compounds, compositions and methods of use |
TW200305422A (en) * | 2002-03-18 | 2003-11-01 | Shionogi & Co | Broad spectrum cefem compounds |
JP4555823B2 (ja) * | 2003-07-11 | 2010-10-06 | セラヴァンス, インコーポレーテッド | 架橋されたグリコペプチド−セファロスポリン抗生物質 |
JPWO2005085258A1 (ja) * | 2004-03-05 | 2007-12-13 | 塩野義製薬株式会社 | 3−ピリジニウムメチルセフェム化合物 |
AU2005202802A1 (en) * | 2004-06-28 | 2006-01-12 | Astellas Pharma Inc. | Cephem compounds |
CN101230070A (zh) * | 2006-12-30 | 2008-07-30 | 黄振华 | 新型抗感染头孢类化合物 |
RS55365B1 (sr) * | 2008-10-31 | 2017-03-31 | Shionogi & Co | Cefalosporin sa kateholskom grupom |
-
2011
- 2011-03-30 KR KR1020110028603A patent/KR101719556B1/ko active IP Right Grant
-
2012
- 2012-03-29 JP JP2014502466A patent/JP6144669B2/ja not_active Expired - Fee Related
- 2012-03-29 AU AU2012237063A patent/AU2012237063B2/en not_active Ceased
- 2012-03-29 PT PT127655892T patent/PT2706062T/pt unknown
- 2012-03-29 WO PCT/KR2012/002302 patent/WO2012134184A2/ko active Application Filing
- 2012-03-29 CA CA2831421A patent/CA2831421C/en not_active Expired - Fee Related
- 2012-03-29 MX MX2013010961A patent/MX359435B/es active IP Right Grant
- 2012-03-29 LT LTEP12765589.2T patent/LT2706062T/lt unknown
- 2012-03-29 DK DK12765589.2T patent/DK2706062T3/en active
- 2012-03-29 CN CN201280015502.0A patent/CN103547583B/zh not_active Expired - Fee Related
- 2012-03-29 HU HUE12765589A patent/HUE039086T2/hu unknown
- 2012-03-29 PL PL12765589T patent/PL2706062T3/pl unknown
- 2012-03-29 ES ES12765589.2T patent/ES2683351T3/es active Active
- 2012-03-29 EA EA201391325A patent/EA024709B1/ru not_active IP Right Cessation
- 2012-03-29 SI SI201231355T patent/SI2706062T1/sl unknown
- 2012-03-29 EP EP12765589.2A patent/EP2706062B1/en active Active
- 2012-03-29 BR BR112013025275A patent/BR112013025275A2/pt not_active Application Discontinuation
- 2012-03-29 SG SG2013072962A patent/SG193998A1/en unknown
- 2012-05-08 US US13/467,019 patent/US8329684B2/en not_active Expired - Fee Related
- 2012-11-30 US US13/691,221 patent/US9630977B2/en not_active Expired - Fee Related
-
2013
- 2013-09-12 IL IL228408A patent/IL228408A/en active IP Right Grant
- 2013-09-26 CO CO13229094A patent/CO6821935A2/es not_active Application Discontinuation
- 2013-09-27 DO DO2013000214A patent/DOP2013000214A/es unknown
- 2013-09-27 CU CU2013000125A patent/CU20130125A7/es unknown
- 2013-09-30 CL CL2013002820A patent/CL2013002820A1/es unknown
- 2013-09-30 CR CR20130501A patent/CR20130501A/es not_active Application Discontinuation
- 2013-10-30 ZA ZA2013/08078A patent/ZA201308078B/en unknown
-
2018
- 2018-07-24 HR HRP20181170TT patent/HRP20181170T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2013010961A (es) | Derivados novedosos de cefalosporinas y composiciones farmaceuticas de estos. | |
PH12017500755A1 (en) | 2 substituted cephem compounds | |
TN2014000417A1 (en) | Heterobicyclic compounds as beta-lactamase inhibitors | |
GEP20156370B (en) | Fluoro-pyridinone derivatives useful as antibacterial agents | |
WO2014209841A3 (en) | Compounds for treating spinal muscular atrophy | |
NZ593892A (en) | Antibiotic compositions for the treatment of gram negative infections | |
MY193277A (en) | Certain amino-pyrimidines, compositions thereof, and methods for their use | |
WO2010047737A3 (en) | Antimicrobial indoline compounds for treatment of bacterial infections | |
EP3216798A3 (en) | Ketolide compounds | |
TN2010000038A1 (en) | Organic compounds | |
NZ596628A (en) | Ketolide compounds having antimicrobial activity | |
NZ740051A (en) | Tetracycline compounds | |
MX2020000576A (es) | Compuestos quimicos. | |
ATE480538T1 (de) | 2-arylmethylazetidincarbapenemderivate und deren herstellung | |
MX2013011272A (es) | Derivado de oxazolidinona novedoso y composicion farmaceutica que incluye el mismo. | |
MX2013002620A (es) | Novedosas n-hidroxi-benzamidas para el tratamiento del cancer. | |
MX2018010177A (es) | Compuestos de 6,7-dihidro-5h-pirazolo[5,1-b][1,3]oxazina-2-carboxa mida. | |
WO2010036000A3 (en) | Novel oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone and pharmaceutical compositions thereof | |
MX2021003485A (es) | Derivados de indano para uso en el tratamiento de infeccion bacteriana. | |
GEP20186874B (en) | Hydrochloride salts of an antibiotic compound | |
ECSP13012902A (es) | Derivados novedosos de cefalosporinas y composiciones farmacéuticas de estos | |
WO2012018662A3 (en) | Fused-imidazoyl compounds useful as antimicrobial agents | |
TH147032A (th) | สารต้านเชื้อแบคทีเรียชนิดใหม่สำหรับรักษาการติดเชื้อแบคทีเรียแกรมบวก | |
UA98166C2 (en) | Use of thieno[3',2':5,6]pyrimidino[2,1-b][1,4,3]thiaselenozin-12-ium salts as bactericide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |